Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐ b ]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2-Reference-Cited by-同舟云学术

Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐ b ]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2

Published:2019-11-07 Issue:24 Volume:14 Page:2093-2101
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Kaieda Akira¹^ORCID,Takahashi Masashi¹^ORCID,Fukuda Hiromi¹,Okamoto Rei¹,Morimoto Shinji¹,Gotoh Masayuki¹,Miyazaki Takahiro¹,Hori Yuri¹,Unno Satoko¹,Kawamoto Tomohiro¹^ORCID,Tanaka Toshimasa¹^ORCID,Itono Sachiko¹,Takagi Terufumi¹,Sugimoto Hiroshi¹^ORCID,Okada Kengo¹,Lane Weston²,Sang Bi‐Ching²,Saikatendu Kumar²,Matsunaga Shinichiro¹,Miwatashi Seiji¹

Affiliation:

1. Pharmaceutical Research DivisionTakeda Pharmaceutical Company Limited 26-1, Muraoka-higashi 2-chome Fujisawa Kanagawa 251-8555 Japan

2. Takeda California 10410 Science Center Drive San Diego CA 92121 USA

Funder

National Institutes of Health

National Institute of General Medical Sciences

Howard Hughes Medical Institute

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link